264 related articles for article (PubMed ID: 24788392)
1. Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.
Pan L; Woodard JL; Lucas DM; Fuchs JR; Kinghorn AD
Nat Prod Rep; 2014 Jul; 31(7):924-39. PubMed ID: 24788392
[TBL] [Abstract][Full Text] [Related]
2. New rocaglamide derivatives from Vietnamese Aglaia species.
Duong NT; Edrada-Ebel R; Ebel R; Lin W; Duong AT; Dang XQ; Nguyen NH; Proksch P
Nat Prod Commun; 2014 Jun; 9(6):833-4. PubMed ID: 25115092
[TBL] [Abstract][Full Text] [Related]
3. Cyclopenta[b]benzofuran and Secodammarane Derivatives from the Stems of Aglaia stellatopilosa.
Othman N; Pan L; Mejin M; Voong JC; Chai HB; Pannell CM; Kinghorn AD; Yeo TC
J Nat Prod; 2016 Apr; 79(4):784-91. PubMed ID: 26974604
[TBL] [Abstract][Full Text] [Related]
4. Structurally Modified Cyclopenta[
Agarwal G; Wilson JR; Kurina SJ; Anaya-Eugenio GD; Ninh TN; Burdette JE; Soejarto DD; Cheng X; Carcache de Blanco EJ; Rakotondraibe LH; Kinghorn AD
J Nat Prod; 2019 Oct; 82(10):2870-2877. PubMed ID: 31621322
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic rocaglamide derivatives from Aglaia duppereana.
El-Neketi M; Ebrahim W; Duong NT; Gedara S; Badria F; Saad HE; Müller WE; Proksch P
Z Naturforsch C J Biosci; 2013; 68(7-8):269-74. PubMed ID: 24066511
[TBL] [Abstract][Full Text] [Related]
6. Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy.
Kim S; Salim AA; Swanson SM; Kinghorn AD
Anticancer Agents Med Chem; 2006 Jul; 6(4):319-45. PubMed ID: 16842234
[TBL] [Abstract][Full Text] [Related]
7. Bioactive flavaglines and other constituents isolated from Aglaia perviridis.
Pan L; Acuña UM; Li J; Jena N; Ninh TN; Pannell CM; Chai H; Fuchs JR; Carcache de Blanco EJ; Soejarto DD; Kinghorn AD
J Nat Prod; 2013 Mar; 76(3):394-404. PubMed ID: 23301897
[TBL] [Abstract][Full Text] [Related]
8. Ponapensin, a cyclopenta[bc]benzopyran with potent NF-kappaB inhibitory activity from Aglaia ponapensis.
Salim AA; Pawlus AD; Chai HB; Farnsworth NR; Douglas Kinghorn A; Carcache-Blanco EJ
Bioorg Med Chem Lett; 2007 Jan; 17(1):109-12. PubMed ID: 17055270
[TBL] [Abstract][Full Text] [Related]
9. Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds.
Schulz G; Victoria C; Kirschning A; Steinmann E
Nat Prod Rep; 2021 Jan; 38(1):18-23. PubMed ID: 32699874
[TBL] [Abstract][Full Text] [Related]
10. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.
Hwang BY; Su BN; Chai H; Mi Q; Kardono LB; Afriastini JJ; Riswan S; Santarsiero BD; Mesecar AD; Wild R; Fairchild CR; Vite GD; Rose WC; Farnsworth NR; Cordell GA; Pezzuto JM; Swanson SM; Kinghorn AD
J Org Chem; 2004 May; 69(10):3350-8. PubMed ID: 15132542
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata.
Pan L; Kardono LB; Riswan S; Chai H; Carcache de Blanco EJ; Pannell CM; Soejarto DD; McCloud TG; Newman DJ; Kinghorn AD
J Nat Prod; 2010 Nov; 73(11):1873-8. PubMed ID: 20939540
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of the potent anticancer Aglaia metabolites (-)-silvestrol and (-)-episilvestrol and the active analogue (-)-4'-desmethoxyepisilvestrol.
Adams TE; El Sous M; Hawkins BC; Hirner S; Holloway G; Khoo ML; Owen DJ; Savage GP; Scammells PJ; Rizzacasa MA
J Am Chem Soc; 2009 Feb; 131(4):1607-16. PubMed ID: 19140688
[TBL] [Abstract][Full Text] [Related]
13. Structure activity relationships of antiproliferative rocaglamide derivatives from Aglaia species (Meliaceae).
Bohnenstengel FI; Steube KG; Meyer C; Nugroho BW; Hung PD; Kiet LC; Proksch P
Z Naturforsch C J Biosci; 1999; 54(1-2):55-60. PubMed ID: 10223787
[TBL] [Abstract][Full Text] [Related]
14. 1H-cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines.
Bohnenstengel FI; Steube KG; Meyer C; Quentmeier H; Nugroho BW; Proksch P
Z Naturforsch C J Biosci; 1999 Dec; 54(12):1075-83. PubMed ID: 10685499
[TBL] [Abstract][Full Text] [Related]
15. Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae).
Ebada SS; Lajkiewicz N; Porco JA; Li-Weber M; Proksch P
Prog Chem Org Nat Prod; 2011; 94():1-58. PubMed ID: 21833837
[No Abstract] [Full Text] [Related]
16. Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas.
Chang LS; Oblinger JL; Burns SS; Huang J; Anderson LW; Hollingshead MG; Shen R; Pan L; Agarwal G; Ren Y; Roberts RD; O'Keefe BR; Kinghorn AD; Collins JM
Mol Cancer Ther; 2020 Mar; 19(3):731-741. PubMed ID: 31848295
[TBL] [Abstract][Full Text] [Related]
17. Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells.
Proksch P; Giaisi M; Treiber MK; Palfi K; Merling A; Spring H; Krammer PH; Li-Weber M
J Immunol; 2005 Jun; 174(11):7075-84. PubMed ID: 15905551
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.
Rivero-Cruz JF; Chai HB; Kardono LB; Setyowati FM; Afriatini JJ; Riswan S; Farnsworth NR; Cordell GA; Pezzuto JM; Swanson SM; Kinghorn AD
J Nat Prod; 2004 Mar; 67(3):343-7. PubMed ID: 15043407
[TBL] [Abstract][Full Text] [Related]
19. Insecticidal rocaglamide derivatives from Aglaia spectabilis (Meliaceae).
Schneider C; Bohnenstengel FI; Nugroho BW; Wray V; Witte L; Hung PD; Kiet LC; Proksch P
Phytochemistry; 2000 Aug; 54(8):731-6. PubMed ID: 11014256
[TBL] [Abstract][Full Text] [Related]
20. Triterpenoids from Aglaia abbreviata and their cytotoxic activities.
Zhang F; Wang JS; Gu YC; Kong LY
J Nat Prod; 2010 Dec; 73(12):2042-6. PubMed ID: 21087017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
